Key Takeaways
• Elekta and Azra AI have announced a strategic partnership to automate cancer registry operations with AI.
• The collaboration integrates Elekta’s registry software with Azra AI’s real-time patient identification and workflow tools.
• The joint solution aims to reduce manual data entry, enhance reporting accuracy, and ensure regulatory compliance.
• The platform is hosted on Axis Cloud and designed to align with major U.S. cancer data reporting standards.
About the Organizations
Elekta
Based in Stockholm, Sweden, Elekta is a global medical technology firm specializing in precision radiation therapy. With over 4,700 employees worldwide, it focuses on delivering cost-effective, personalized cancer care solutions.
Azra AI
Azra AI is the only U.S.-based company offering a fully automated, end-to-end oncology workflow solution. Its platform uses natural language processing and AI to extract clinical insights and support registry and documentation processes.
Cancer registrars play a vital role in documenting patient data used for treatment planning, epidemiological studies, and public health reporting.
However, the increasing volume and complexity of clinical data have put pressure on registry teams to perform more with fewer resources. Manual casefinding, data abstraction, and compliance documentation remain time-consuming and error-prone tasks.
This is where the Elekta–Azra AI partnership seeks to intervene.
The partnership brings together Elekta’s ONE Registry Informatics software, a cloud-based cancer registry platform, and Azra AI’s intelligent automation engine, designed to:
• Automatically identify reportable cancer cases in real time
• Reduce reliance on manual data entry
• Standardize data for compliance with national and international reporting agencies
The Technology: Automation Meets Compliance
Elekta’s ONE Registry Informatics system—deployed via Axis Cloud—is engineered to optimize registry workflows and enhance data integrity. The software is built with compliance in mind, supporting guidelines from:
• American College of Surgeons Commission on Cancer (CoC)
• North American Association of Central Cancer Registries (NAACCR)
• Surveillance, Epidemiology, and End Results (SEER) Program
By integrating Azra AI’s real-time casefinding tools, registry professionals can proactively identify new cancer diagnoses from clinical documentation without waiting for delayed coding or manual reporting.
This automation helps in accelerating abstraction timelines and reducing backlogs, particularly in under-resourced hospitals or cancer centers.
Global Scope and Limitations
Although Elekta operates in over 40 countries, the company has noted that the ONE Registry Informatics solution may not yet be available in all markets.
Nonetheless, the demand for AI-powered registry automation is growing worldwide, particularly as oncology departments grapple with staff shortages, data complexity, and stricter compliance mandates.
The platform will be showcased at the 2025 National Cancer Registrars Association (NCRA) Annual Education Conference, scheduled from May 3–6 in Orlando, where Elekta will host product demos and expert Q&A sessions at booths #205, 207, and 209.
Industry Perspective: Why This Matters
This partnership is significant not only because of the technical capabilities it introduces but also because it addresses a systemic bottleneck in the cancer care continuum.
With the increasing use of cancer data for AI research, personalized treatment, and national health policy planning, registry accuracy and timeliness are more crucial than ever.
Health IT experts and registrars have long called for tools that can:
• Reduce the administrative overhead of registry work
• Ensure data quality and regulatory adherence
• Streamline cancer case identification and abstraction
By tackling these pain points head-on, Elekta and Azra AI are helping set a new benchmark for digital oncology operations.
March 26, 2025: U.S. Blacklists China Firms to Halt AI Surge March 24, 2025: Ant Group Backs China-Made Chips to Train AI March 19, 2025: Tencent’s AI Strategy Could Drive China Tech Stocks Higher!
For more news and insights, visit AI News on our website.
